histidinol has been researched along with carmustine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dykes, D; Malspeis, L; Plowman, J; Waud, W; Zaharko, D | 1 |
| Fang, WD; Warrington, RC | 1 |
2 other study(ies) available for histidinol and carmustine
| Article | Year |
|---|---|
L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Histidinol; Humans; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Heterologous | 1992 |
L-histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemia.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Female; Histidinol; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred DBA | 1989 |